Skip to content

Restylane Silk for Photoaged Thinned Hands

Restylane Silk for Photoaged Thinned Hands

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02780258
Enrollment
25
Registered
2016-05-23
Start date
2015-10-20
Completion date
2016-10-28
Last updated
2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Photoaged Thinning of the Hands

Brief summary

To evaluate the safety and efficacy of Restylane Silk for photoaged thinned hands

Interventions

Sponsors

Skin Laser & Surgery Specialists
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Female volunteer * Aged from 40-70 years on the day of screening * No known medical conditions that may interfere with study participation * Moderate to very severe Photoaged thinning of the hands based on the 5-point hand grading scale * Willingness to not use any products on their hands for the duration of the study * Read, understand, and sign informed consent forms * Willingness to sign photography release form * Willing and able to comply with all follow-up requirements * Willingness to undergo Restylane Silk injections to one hand

Exclusion criteria

* Any significant skin disease at treatment area * Any medical condition which could interfere with the treatment * Inability or unwillingness to follow the treatment schedule * Inability or unwillingness to sign the informed consent * History of poor wound healing * History of keloid formation * History of HIV, hepatitis, immuno-compromised * Pregnant or lactating * Previous use of deep chemical peels on the treatment area * Previous injections of Restylane Silk to the hands * Known hypersensitivity to Restylane Silk or any of its ingredients * Previous laser or light based treatments to the treatment area 6 months prior to the screening visit

Design outcomes

Primary

MeasureTime frame
Change in photoaged thinning of the treatment area as measured by the 5 point hand grading scaleBaseline, 1month, 3months, 6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026